Skip to content
Lower risk Drug recall · FDA · Published March 5, 2020

Teva Epinephrine Auto-Injector Recall: Out-of-specification trigger force

Teva recalls Epinephrine Injection USP 0.3 mg auto-injectors due to out-of-specification trigger force in a non-marketed lot. This may affect safety during use.

🇺🇸 FDA recall #D-1260-2020DrugTeva ›
Take action

Contact the company

Recalling firmTeva Pharmaceuticals USA400 Interpace Pkwy · Parsippany, NJ 07054-1120
✎ GovInfoNow plain-language explainer

What happened, in plain English

Teva is recalling a specific lot of epinephrine auto-injectors because the trigger force was out of specification. This could potentially affect the device's safety during use, though the recall is limited to a specific non-marketed lot. Read more at govinfonow.com/recall/37346-teva-epinephrine-auto-injector-recall-out-of-specification-trigger-force.

Source Summary by GovInfoNow · govinfonow.com/recall/37346-teva-epinephrine-auto-injector-recall-out-of-specification-trigger-force · Updated October 5, 2026 · FDA enforcement record: FDA #D-1260-2020

Cite this page

“Teva Epinephrine Auto-Injector Recall: Out-of-specification trigger force.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37346-teva-epinephrine-auto-injector-recall-out-of-specification-trigger-force. Based on FDA recall #D-1260-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1260-2020%22&limit=1).

Why it’s dangerous

The recall involves a non-marketed lot where the trigger force for the epinephrine injector was out of specification. This could mean the device might not function properly during an emergency, though the risk is limited to this specific lot.

Who’s affected

People with a prescription for Teva's Epinephrine Injection USP 0.3 mg auto-injector who received the specific lot number 007F19AA (expiring April 2021) are affected. Those using the device for medical emergencies are at most risk.

How to tell if you have this one

Check the product label for the lot number 007F19AA and expiration date of April 2021. The product is a prescription-only epinephrine auto-injector with NDC code 0093-5986-27.

  • Brand
    Teva
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the lot number 007F19AA and expiration date of April 2021 on the product label.

How this recall unfolded

Recall timeline

FDA terminated this recall 9 months after the firm started it.

1. Firm started the recall: Mar 5, 202012. FDA classified it Class II: May 5, 202023. Published in FDA’s Enforcement Report: May 13, 202034. FDA terminated the recall: Nov 19, 202042020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1260-2020 (March 5, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1260-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA